Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Sweden
/
Mats Anders Nilsson
MA
Mats Anders Nilsson
Stakeholder, STOCKBY PHARMA
Stockbyvägen 5 Lgh 1002
SE
8 active roles
Share
Overview
Companies & roles
Network
Loading profile…
Companies & roles
Active roles
8 positions
Company
Role
Period
Ownership
Status
STOCKBY PHARMA
CVR 4711260176
Other
Stakeholder
Since 2017
—
Active
Antero Medical Consulting Aktiebolag
CVR 5565246369
Board
Deputy Board Member
Since 2022
—
Active
Antero Medical AB
CVR 5566415039
Board
Deputy Board Member
Since 2022
—
Active
Uderm AB
CVR 5590489737
Board
Deputy Board Member
Since 2022
—
Active
MFN Medical AB
CVR 5591337646
Board
Deputy Board Member
Since 2022
—
Active
Hudläkargruppen i Stockholm AB
CVR 5591997076
Board
Deputy Board Member
Since 2022
—
Active
Bostadsrättsföreningen Byggmästaren 14
CVR 7164197571
Board
Board of Directors
Since 2026
—
Active
Hud och Pharma M N Handelsbolag
CVR 9696495101
Owner
Owner
Since 2022
—
Active
Historical roles
3 positions
Company
Role
Period
Ownership
Status
Karessa Pharma Holding AB (publ)
CVR 5569421596
Management
Chief Executive Officer
2019 – 2020
—
Dissolved
Karessa Pharma AB
CVR 5569667420
Management
Chief Executive Officer
2020 – 2022
—
Dissolved
Karessa Incentive AB
CVR 5591148514
Board
Board of Directors
2020 – 2022
—
Dissolved
3 dissolved companies in directorship history
Karessa Pharma Holding AB (publ)
CVR 5569421596 · Dissolved 2020 · —
Role: Chief Executive Officer
Karessa Pharma AB
CVR 5569667420 · Dissolved 2022 · —
Role: Chief Executive Officer
Karessa Incentive AB
CVR 5591148514 · Dissolved 2022 · —
Role: Board of Directors
More on Mats Anders Nilsson
Overview →
Headline figures, risk signals and profile summary
Network →
Connections across other directors and entities